GenMark Diagnostics, Inc. reported preliminary revenue results for the fourth quarter 2015. Preliminary fourth quarter 2015 revenue was $13.2 million, an increase of 35% over the prior year period.

The company expects full year 2015 revenue to be $39.4 million, an increase of 29% versus 2014.

The company still expects a first quarter 2016 launch of ePlex in Europe and 510(k) submission to the FDA in the second quarter of 2016.